Description of Research Expertise:
Heparin-induced thrombocytopenia, Immune thrombocytopenia, Thrombosis, Anticoagulation, Platelet disorders, Bleeding disorders
Cuker A, Rux AH, Hinds JL, Dela Cruz M, Yarovoi SV, Brown IAM, Yang W, Konkle BA, Arepally GM, Watson SP, Cines DB: Novel diagnostic assays for heparin-induced thrombocytopenia Blood 121 (18): 3727-3732,2013.
Cuker A: Protamine-induced thrombocytopenia? Blood 121 : 2818-2819,2013.
Siegal D: Reversal of novel oral anticoagulants in patients with major bleeding J Thromb Thrombolysis 35 (3): 391-398,2013.
Sood S, Cuker A, Wang C, Metjian A, Chiang E, Soucie J: Similarity in Joint Function Limitation in Type 3 Von Willebrand Disease and Moderate Haemophilia A Haemophilia 19 (4): 595-601,2013.
Tanhehco YC, Cuker A, Rudnick M: Investigation of a potential protective mechanism against heparin-induced thrombocytopenia in patients on chronic intermittent hemodialysis Thromb Res 131 (3): 244-248,2013.
Cuker A, Gimotty PA, Crowther MA: Predictive value of the 4Ts scoring system for heparin-induced thromboctopenia: a systematic review and meta-analysis Blood 120 (20): 4160-4167,2012.
Sachais BS, Litvinov RI, Yarovoi SV, Rauova L, Hinds JL, Rux AH, Arepally GM, Poncz M, Cuker A, Weisel JW: Dynamic antibody binding properties in the pathogenesis of HIT Blood 120 (5): 1137-1142,2012.
Martinez M, Cuker A, Mills A, Lightfoot R, Fan Y, Tang W, Hazen SL: Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolism Free Radic Biol Med 53 (2): 230-236,2012.
Cuker A: How I treat heparin-induced thrombocytopenia Blood 119 (10): 2209-2218,2012.
Lakshmanan S: Comtemporary management of primary immune thrombocytopenia (ITP) in adults J Thromb Haemost 10 (10): 1988-1998,2012.